Strategic Financial Services Inc. Has $204,000 Stock Holdings in Danaher Co. (NYSE:DHR)

Strategic Financial Services Inc. boosted its position in shares of Danaher Co. (NYSE:DHR) by 19.4% in the fourth quarter, Holdings Channel reports. The firm owned 887 shares of the conglomerate’s stock after purchasing an additional 144 shares during the period. Strategic Financial Services Inc.’s holdings in Danaher were worth $204,000 at the end of the most recent quarter.

Several other hedge funds also recently bought and sold shares of DHR. Heck Capital Advisors LLC acquired a new stake in shares of Danaher during the fourth quarter worth about $27,000. Decker Retirement Planning Inc. bought a new stake in Danaher during the 4th quarter worth approximately $31,000. Golden State Wealth Management LLC acquired a new stake in Danaher during the 4th quarter worth approximately $31,000. Teachers Insurance & Annuity Association of America acquired a new position in shares of Danaher in the third quarter valued at approximately $39,000. Finally, Pineridge Advisors LLC increased its position in shares of Danaher by 63.3% during the fourth quarter. Pineridge Advisors LLC now owns 147 shares of the conglomerate’s stock worth $34,000 after acquiring an additional 57 shares in the last quarter. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Danaher Stock Down 1.4 %

DHR opened at $209.90 on Thursday. The company has a current ratio of 1.40, a quick ratio of 1.05 and a debt-to-equity ratio of 0.31. The business’s 50-day moving average price is $218.48 and its 200-day moving average price is $239.46. The company has a market cap of $150.02 billion, a P/E ratio of 39.75, a P/E/G ratio of 2.66 and a beta of 0.82. Danaher Co. has a 12 month low of $196.80 and a 12 month high of $281.70.

Danaher (NYSE:DHR) last posted its earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share (EPS) for the quarter, hitting the consensus estimate of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same period in the previous year, the firm earned $2.09 EPS. On average, equities analysts expect that Danaher Co. will post 7.63 EPS for the current year.

Danaher Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Friday, March 28th will be issued a $0.32 dividend. This is an increase from Danaher’s previous quarterly dividend of $0.27. The ex-dividend date is Friday, March 28th. This represents a $1.28 dividend on an annualized basis and a yield of 0.61%. Danaher’s dividend payout ratio is 24.24%.

Analyst Ratings Changes

A number of brokerages have recently commented on DHR. Barclays cut their price target on Danaher from $275.00 to $240.00 and set an “equal weight” rating on the stock in a report on Thursday, January 30th. Wells Fargo & Company cut their target price on Danaher from $280.00 to $240.00 and set an “equal weight” rating on the stock in a research note on Thursday, January 30th. The Goldman Sachs Group set a $250.00 price target on shares of Danaher in a research note on Wednesday, January 15th. Scotiabank began coverage on shares of Danaher in a research report on Monday, December 23rd. They issued a “sector perform” rating and a $265.00 price objective on the stock. Finally, Raymond James reaffirmed a “market perform” rating on shares of Danaher in a research report on Monday, February 3rd. Six equities research analysts have rated the stock with a hold rating and sixteen have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $277.76.

Insider Activity at Danaher

In other Danaher news, SVP Brian W. Ellis sold 5,700 shares of the business’s stock in a transaction on Thursday, January 30th. The stock was sold at an average price of $224.13, for a total value of $1,277,541.00. Following the sale, the senior vice president now directly owns 20,230 shares of the company’s stock, valued at approximately $4,534,149.90. The trade was a 21.98 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. 10.90% of the stock is currently owned by corporate insiders.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.